Comerica Inc
NYSE:CMA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
45.7458
72.73
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Comerica Inc
Wall Street
Price Targets
CMA Price Targets Summary
Comerica Inc
According to Wall Street analysts, the average 1-year price target for
CMA
is 72.61 USD
with a low forecast of 56.21 USD and a high forecast of 89.25 USD.
CMA Last Price Targets
Comerica Inc
The latest public price target was made on Nov 18, 2024 by
David George
from
Robert W. Baird
,
who expects
CMA
stock to
rise by 28%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
David George
Robert W. Baird
|
80
USD
Upside 28% |
1 month ago
Nov 18, 2024
|
Comerica (CMA) PT Raised to $80 at Baird
StreetInsider
|
Jason Goldberg
Barclays
|
66
USD
Upside 6% |
2 months ago
Oct 21, 2024
|
Comerica Analysts Boost Their Forecasts After Better-Than-Expected Earnings
Benzinga
|
Brandon King
Truist Financial
|
70
USD
Upside 12% |
2 months ago
Oct 21, 2024
|
Comerica Analysts Boost Their Forecasts After Better-Than-Expected Earnings
Benzinga
|
Manan Gosalia
Morgan Stanley
|
67
USD
Upside 7% |
2 months ago
Oct 21, 2024
|
Comerica price target raised to $67 from $63 at Morgan Stanley
TheFly
|
|
Terry McEvoy
Stephens
|
70
USD
Upside 12% |
2 months ago
Oct 21, 2024
|
Comerica (CMA) PT Raised to $70 at Stephens
StreetInsider
|
Keith Horowitz
Citigroup
|
63
USD
Upside 1% |
2 months ago
Oct 21, 2024
|
Comerica (CMA) PT Raised to $63 at Citi
StreetInsider
|
Michael Rose
Raymond James
|
70
USD
Upside 12% |
2 months ago
Oct 21, 2024
|
Comerica (CMA) PT Raised to $70 at Raymond James
StreetInsider
|
John Pancari
Evercore ISI
|
64
USD
Upside 3% |
2 months ago
Oct 18, 2024
|
Evercore ISI on Comerica (CMA): 'Constructive on NII & NIM Outlook, Despite Growth Headwinds'
StreetInsider
|
|
Manan Gosalia
Morgan Stanley
|
63
USD
Upside 1% |
2 months ago
Sep 30, 2024
|
Comerica price target raised to $63 from $61 at Morgan Stanley
TheFly
|
|
David Rochester
Compass Point
|
56
USD
Downside 10% |
5 months ago
Jul 23, 2024
|
Comerica price target lowered to $56 from $63 at Compass Point
TheFly
|
Peter Winter
D.A. Davidson
|
55
USD
Downside 12% |
5 months ago
Jul 22, 2024
|
DA Davidson Reiterates Neutral Rating on Comerica (CMA), PT $55
StreetInsider
|
|
David George
Robert W. Baird
|
65
USD
Upside 4% |
5 months ago
Jul 22, 2024
|
Comerica (CMA) PT Lowered to $65 at Baird
StreetInsider
|
Scott Siefers
Piper Sandler
|
52
USD
Downside 17% |
5 months ago
Jul 22, 2024
|
Comerica (CMA) PT Raised to $52 at Piper Sandler
StreetInsider
|
Jon Arfstrom
RBC Capital
|
56
USD
Downside 10% |
5 months ago
Jul 22, 2024
|
Comerica (CMA) PT Lowered to $56 at RBC Capital
StreetInsider
|
|
Michael Rose
Raymond James
|
60
USD
Downside 4% |
5 months ago
Jul 2, 2024
|
Comerica upgraded to Outperform from Market Perform at Raymond James
TheFly
|
|
David George
Robert W. Baird
|
68
USD
Upside 9% |
6 months ago
Jun 20, 2024
|
Comerica price target lowered to $68 from $72 at Baird
TheFly
|
|
Jon Arfstrom
RBC Capital
|
58
USD
Downside 7% |
6 months ago
Jun 12, 2024
|
Comerica (CMA) PT Lowered to $58 at RBC Capital
StreetInsider
|
Mike Mayo
Wells Fargo
|
48
USD
Downside 23% |
7 months ago
May 24, 2024
|
Comerica (CMA) PT Lowered to $48 at Wells Fargo
StreetInsider
|
Erika Najarian
UBS
|
55
USD
Downside 12% |
8 months ago
Apr 19, 2024
|
Comerica (CMA) PT Lowered to $55 at UBS
StreetInsider
|
|
Scott Siefers
Piper Sandler
|
54
USD
Downside 13% |
8 months ago
Apr 19, 2024
|
Comerica (CMA) PT Raised to $54 at Piper Sandler
StreetInsider
|
|
Jon Arfstrom
RBC Capital
|
62
USD
Downside 1% |
8 months ago
Apr 19, 2024
|
Comerica (CMA) PT Raised to $62 at RBC Capital
StreetInsider
|
|
Peter Winter
D.A. Davidson
|
57
USD
Downside 9% |
8 months ago
Apr 19, 2024
|
Comerica (CMA) PT Raised to $57 at DA Davidson
StreetInsider
|
|
David George
Robert W. Baird
|
72
USD
Upside 15% |
8 months ago
Apr 19, 2024
|
Comerica (CMA) PT Raised to $72 at Baird
StreetInsider
|
Bernard von-Gizycki
Deutsche Bank
|
59
USD
Downside 5% |
8 months ago
Apr 10, 2024
|
Comerica initiated with a Hold at Deutsche Bank
TheFly
|
|
Brandon King
Truist Financial
|
62
USD
Downside 1% |
8 months ago
Apr 1, 2024
|
Comerica price target raised to $62 from $60 at Truist
TheFly
|
|
Richard Bove
Odeon Capital Group LLC
|
47.24
USD
Downside 24% |
1 year ago
Jun 5, 2023
|
Odeon Capital Upgrades Comerica (CMA) to Buy; 'Unlikely to Fail'
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CMA's stock price target?
Price Target
72.61
USD
According to Wall Street analysts, the average 1-year price target for
CMA
is 72.61 USD
with a low forecast of 56.21 USD and a high forecast of 89.25 USD.
What is Comerica Inc's Revenue forecast?
Projected CAGR
0%
For the last 8 years the
compound annual growth rate for
Comerica Inc's revenue is
4%.
The projected
CAGR
for the next 4 years is
0%.
What is Comerica Inc's Net Income forecast?
Projected CAGR
0%
For the last 8 years the
compound annual growth rate for
Comerica Inc's net income is
7%.
The projected
CAGR
for the next 4 years is
0%.
You don't have any saved screeners yet
